Keith A. Kucinski serves as Executive at Matinas BioPharma Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Keith A. Kucinski has executed 2 insider transactions totaling $115.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 25, 2019 involved purchasing 58,000 shares valued at $71.3K.
Keith A. Kucinski currently holds 94,500 shares of Matinas BioPharma Holdings, Inc. (MTNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith A. Kucinski has been a net buyer of MTNB stock. They have purchased $115.1K and sold $0 worth of shares.
Keith A. Kucinski's most recent insider trade was on Nov 25, 2019, when they purchased 58,000 shares at $1.23 per share.
Get notified when new Form 4 filings are submitted
| $1.20 |
| Discretionary |